Ekf Diagnostics Holding PLC (LON:EKF)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $32.69 and traded as low as $29.78. Ekf Diagnostics shares last traded at $30.72, with a volume of 97,963 shares traded.
The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.34 and a current ratio of 1.81. The stock has a market cap of $139.50 million and a P/E ratio of 13.36. The firm’s 50 day moving average is GBX 32.19 and its 200 day moving average is GBX 32.69.
Ekf Diagnostics Company Profile (LON:EKF)
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Africa, and internationally. It offers DiaSpect Tm, an hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a centrifuge that provides a hematocrit reading for six blood samples.
Recommended Story: Investing in Blue-Chip Stocks
Receive News & Ratings for Ekf Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekf Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.